NM-05

N/A

Report date: 2025/10/21 15:09:19

Base Information

Drug NameNM-05
Drug Alias NameNM-05NM-05 TRT
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionPositron-emission tomography enhancersIonising radiation emittersFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanomab
China Registration ClassN/A

Develop Information

Active CompaniesNanomab
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A